Anton Vladić
Impact in
-
- Multiple Sclerosis Research Studies
- Neurology top 5%
- Peripheral Neuropathies and Disorders
Papers in
-
- Multiple Sclerosis Research Studies 12
- Oncology 7
- Polyomavirus and related diseases 2
- Drug Transport and Resistance Mechanisms 2
- CAR-T cell therapy research 2
- Co-authors
- David Margolin (6 shared papers)Vesna Brinar (7 shared papers)Jeffrey Palmer (2 shared papers)Marijan Klarica (4 shared papers)Krzysztof Selmaj (4 shared papers)Edward Fox (5 shared papers)Alasdair Coles (5 shared papers)Ann Bass (4 shared papers)
In The Last Decade
Anton Vladić
25 papers receiving 702 citations
Peers
Comparison fields: 5 of 59
- Pathology and Forensic Medicine 435
- Neurology 161
- Immunology 167
- Rheumatology 83
- Oncology 139
Countries citing papers authored by Anton Vladić
This map shows the geographic impact of Anton Vladić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Vladić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Vladić more than expected).
Fields of papers citing papers by Anton Vladić
This network shows the impact of papers produced by Anton Vladić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Vladić. The network helps show where Anton Vladić may publish in the future.
Co-authors
The 25 scholars most cited alongside Anton Vladić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 194 | |
| 2 | 2013 | 115 | |
| 3 | 2011 | 102 | |
| 4 | 2016 | 55 | |
| 5 | 2002 | 52 | |
| 6 | 2013 | 39 | |
| 7 | 2004 | 33 | |
| 8 | 2008 | 20 | |
| 9 | 2002 | 19 | |
| 10 | 2000 | 16 | |
| 11 | 1994 | 15 | |
| 12 | 2013 | 11 | |
| 13 | 2014 | 9 | |
| 14 | 2022 | 8 | |
| 15 | 2017 | 8 | |
| 16 | Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression. | 2011 | 7 |
| 17 | 2017 | 6 | |
| 18 | 2016 | 6 | |
| 19 | Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months | 2016 | 6 |
| 20 | 2016 | 5 |
About Anton Vladić
Anton Vladić is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Rheumatology and Psychiatry and Mental health, having authored 26 papers that have together received 734 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (12 papers), Immunotherapy and Immune Responses (3 papers), Cerebrospinal fluid and hydrocephalus (2 papers), Polyomavirus and related diseases (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Migraine and Headache Studies (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (435 citations), Neurology (161 citations), Immunology (167 citations), Rheumatology (83 citations) and Oncology (139 citations). Anton Vladić has collaborated with scholars based in Croatia, Italy and Czechia. Frequent co-authors include David Margolin, Vesna Brinar, Jeffrey Palmer, Marijan Klarica, Krzysztof Selmaj, Edward Fox, Alasdair Coles, Ann Bass, Susan Moran and D. A. S. Compston. Their work appears in journals such as Neurology, Journal of Neuroimmunology, Neuroscience, The Journal of Clinical Endocrinology & Metabolism and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.